Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 66 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,180 | -14.7% | 1,501 | +6.2% | 0.00% | – |
| Q2 2023 | $9,594 | +31880.0% | 1,413 | -76.0% | 0.00% | -100.0% |
| Q1 2023 | $30 | +900.0% | 5,899 | +924.1% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 576 | -63.6% | 0.00% | – |
| Q3 2022 | $23,000 | -63.5% | 1,584 | -62.1% | 0.00% | -100.0% |
| Q2 2022 | $63,000 | +85.3% | 4,184 | +45.3% | 0.00% | – |
| Q1 2022 | $34,000 | -34.6% | 2,880 | -9.3% | 0.00% | -100.0% |
| Q4 2021 | $52,000 | -18.8% | 3,175 | +41.6% | 0.00% | -50.0% |
| Q3 2021 | $64,000 | +4.9% | 2,243 | +25.0% | 0.00% | 0.0% |
| Q2 2021 | $61,000 | -50.0% | 1,795 | -55.7% | 0.00% | 0.0% |
| Q1 2021 | $122,000 | -11.6% | 4,049 | +44.7% | 0.00% | -50.0% |
| Q4 2020 | $138,000 | +273.0% | 2,799 | +189.5% | 0.00% | – |
| Q3 2020 | $37,000 | -68.1% | 967 | -64.0% | 0.00% | -100.0% |
| Q2 2020 | $116,000 | +582.4% | 2,683 | +386.1% | 0.01% | +400.0% |
| Q4 2019 | $17,000 | 0.0% | 552 | -25.4% | 0.00% | 0.0% |
| Q2 2019 | $17,000 | +183.3% | 740 | +244.2% | 0.00% | – |
| Q1 2019 | $6,000 | -14.3% | 215 | -39.8% | 0.00% | -100.0% |
| Q4 2018 | $7,000 | – | 357 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
| Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
| MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
| Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
| Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
| Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
| Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
| ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
| Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
| Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |